fostamatinib open-label
Showing 1 - 25 of >10,000
Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)
Recruiting
- Refractory Chronic Myelomonocytic Leukemia
- Refractory Myelodysplastic Syndrome
-
Houston, TexasM D Anderson Cancer Center
Aug 31, 2021
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium)
Enrolling by invitation
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
-
Los Angeles, California
- +36 more
Mar 2, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial in Canada, United States (Fostamatinib 150 mg bid)
Completed
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib 150 mg bid
-
Gilbert, Arizona
- +35 more
Jul 19, 2021
Immune Thrombocytopenic Purpura Trial in Worldwide (Fostamatinib Disodium)
Completed
- Immune Thrombocytopenic Purpura
- Fostamatinib Disodium
-
Tucson, Arizona
- +54 more
May 21, 2021
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Chronic Pain Trial (Placebo)
Not yet recruiting
- Chronic Pain
- Placebo
- (no location specified)
Jul 17, 2023
Malaria Trial (Meplazumab for Injection)
Not yet recruiting
- Malaria
- Meplazumab for Injection
- (no location specified)
Sep 13, 2023
Open Angle Glaucoma Trial in Geneva (contact lens sensor (CLS) SENSIMED Triggerfish®)
Terminated
- Open Angle Glaucoma
- contact lens sensor (CLS) SENSIMED Triggerfish®
-
Geneva, SwitzerlandUniversity Hospital Geneva
May 16, 2023
Motion Sickness Trial in Santa Monica (Tradipitant)
Recruiting
- Motion Sickness
-
Santa Monica, CaliforniaSanta Monica Clinical Trials
Nov 13, 2023
Pulmonary Hypertension, Interstitial Lung Disease Trial (LIQ861)
Not yet recruiting
- Pulmonary Hypertension
- Interstitial Lung Disease
- LIQ861
- (no location specified)
Nov 10, 2023
Pain, Postoperative Trial in Lausanne (Placebo)
Not yet recruiting
- Pain, Postoperative
- Placebo
-
Lausanne, Vaud, SwitzerlandCentre de Médecine Intégrative et Complémentaire, Service d'anes
Oct 24, 2023
Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
- Sickle Cell Disease
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2023
Hypertension Trial in Hosszuheteny (Nebivolol 5 mg, Ramipril 2.5/5/10 mg)
Recruiting
- Hypertension
- Nebivolol 5 mg
- Ramipril 2.5/5/10 mg
-
Hosszuheteny, HungaryA & P Kft.
Oct 23, 2023
Safety Issues Trial (Nicotinamide Riboside)
Recruiting
- Safety Issues
- Nicotinamide Riboside
-
Bergen, Vestland, NorwayHaukeland University Hospital
Nov 25, 2022
Alpha 1-Antitrypsin Deficiency, Emphysema Trial (INBRX-101)
Not yet recruiting
- Alpha 1-Antitrypsin Deficiency
- Emphysema
- (no location specified)
May 31, 2023
Thyroid Eye Disease, TED Trial in Shanghai (IBI311)
Recruiting
- Thyroid Eye Disease, TED
-
Shanghai, Shanghai, ChinaNinth People's Hospital Affiliated to Shanghai Jiao Tong Univers
Nov 9, 2023
Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Jul 31, 2023
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- Ceftibuten
- (no location specified)
Nov 27, 2023
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- CABA-201
-
Boston, MassachusettsMassachusetts General Hospital
Nov 7, 2023
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, TBS-DMPFC)
Not yet recruiting
- Treatment Resistant Depression
- Active TBS-DLPFC
- TBS-DMPFC
-
Stanford, CaliforniaStanford University
Sep 18, 2023
Becker Muscular Dystrophy Trial in Atlanta (EDG-5506)
Enrolling by invitation
- Becker Muscular Dystrophy
-
Atlanta, GeorgiaRare Disease Research
Sep 27, 2023
Ovarian Epithelial Carcinoma Trial (SZ011 CAR-NK)
Not yet recruiting
- Ovarian Epithelial Carcinoma
- SZ011 CAR-NK
- (no location specified)
May 3, 2023
Advanced Hepatocellular Carcinoma Trial (SZ003 CAR-NK)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- SZ003 CAR-NK
- (no location specified)
Apr 25, 2023